Interestingly, the IL-receptor antagonist anakinra prevented the defective relaxation evoked by the in vivo infusion, confirming IL-1β as a key mediator of endothelial dysfunction induced by visfatin/eNampt. Here, NAMPT is linked to endothelial dysfunction.